We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Netherlands Drug Authority Aims to Eliminate Backlog by 2011
Netherlands Drug Authority Aims to Eliminate Backlog by 2011
March 17, 2009
The Dutch Medicines Evaluation Board (MEB) will limit the number of assessments that it permits for each product application as part of its strategy to eliminate all assessment backlogs by 2011.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor